The South African Health Products Authority (SAHPRA) on Wednesday approved the use of Pfizer's Comirnaty COVID-19 vaccine after BioNTech and Pfizer announced that two doses of their vaccine may not be enough to protect against the Omicron variant.
The Department of International Relations and Cooperation (DIRCO) in a statement urged world leaders not to implement 'knee-jerk' policy decisions in response to the detection of the Omicron variant.
South African experts have expressed concern about the rising number of COVID-19 infections among young children, even as the country recorded a further 16,055 infections and 25 deaths overnight on Friday.
The move came soon after Belgium confirmed a case of the B.1.1.529 variant in someone who had travelled back from Egypt earlier this month, with the European Union (EU) member states agreeing to a snap travel ban on seven African nations.
The UK's health authorities have confirmed that a new and "most significant" variant of COVID-19 is officially under investigation in the country as the government on Friday added six countries to its travel ban red list from southern Africa, where B.1.1.529 strain was first identified.